Carnegie Pharmaceuticals, LLC - Sept. 3, 2020
Sep 03, 2020
President and CEO
600 Delran Pkwy.
Aug 24, 2020 - Sep 03, 2020
Control procedures are not established which monitor the output and demonstrate the performance of those manufacturing processes that may be responsible for causing variability in the characteristics of in-process material and the drug product.Investigator(s): Frederick Razzaghi